Alkermes PLC is a fully integrated, biopharmaceutical company. It applies its scientific expertise and proprietary technologies to research, develop and commercialize pharmaceutical products to address unmet medical needs of patients.
| Website: | www.alkermes.com |
| Email: | financial@alkermes.com |
| Main Phone: | +353 17728000 |
| Address: | 1 Burlington Road |
| Address 2: | Connaught House |
| City / Town: | Dublin |
| Country: | IRL |
| Postal Code: | 4 |
| Exchange: | NGS |
| CEO: | Richard F. Pops |
| Employees: | 1750 |
| Issuer Type: | CS - Common Stock |
| Sector/Industry: | Healthcare |
| NAICS: | Pharmaceutical P |
| Last Price 46.04 | Change $ -0.11 | Change % -0.24 | Tick N/A |
| Bid 45.96 | Bid Size 100.00 | Ask 46.07 | Ask Size 100.00 |
| Open 46.37 | High 46.95 | Low 45.40 | Prev Close 46.15 |
| Last Trade | Volume 464,714 | 52 Wk Hi 71.22 | 52 Wk Low 41.15 |
| Market Cap 7.1 bi | Ex-Div Date N/A | Div Rate N/A | Yield N/A |
| Shares 155,001,248.00 | EPS (TTM) -1.03 | PE Ratio N/A | Exchange NGS |
|
|
|
|
| Last 3 Mo | Last 12 Mo | |
|---|---|---|
| Number of Insider Trades | 28 | 213 |
| Number of Buys | 16 | 104 |
| Number of Sells | 12 | 109 |
| Net Activity | 36897 | 241722 |
| Last 10 Buys | Shares |
|---|---|
| David W. Anstice | 1,000 |
| Wendy L. Dixon | 1,000 |
| Mark Stejbach | 1,000 |
| Floyd E Bloom | 1,000 |
| David W. Anstice | 1,000 |
| Last 10 Sell | Shares |
|---|---|
| Paul J. Mitchell | 1,000 |
| Elliot W. Ehrich | 1,000 |
| Elliot W. Ehrich | 1,000 |
| Paul J. Mitchell | 1,000 |
| Paul J. Mitchell | 1,000 |
| Paul J. Mitchell | 1,000 |
| Michael J. Landine | 1,000 |
| Michael J. Landine | 1,000 |
| Richard F. Pops | 1,000 |
| Iain M. Brown | 1,000 |
| Current | 1 Week Ago | 2 Weeks Ago | 3 Weeks Ago | |
|---|---|---|---|---|
| High Target Price Estimate | 66 | 77 | 77 | 66 |
| Low Target Price Estimate | 60 | 60 | 60 | 60 |
| Mean Target Price Estimate | 62.67 | 66.25 | 66.25 | 62.67 |
| Standard Deviation | 3.06 | 7.59 | 7.59 | 3.06 |
| Date of Most Recent Estimate | 07/29/16 | 07/29/16 | 07/29/16 | 08/19/16 |
| Form Type | Form Description | Pages | Date |
|---|---|---|---|
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-08-08 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-08-05 |
| 8-K | Report of unscheduled material events or corporate changes. | 3 | 2016-07-29 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-07-28 |
| 10-Q | Quarterly report with a continuing view of a company's financial position | 39 | 2016-07-28 |
| 8-K | Report of unscheduled material events or corporate changes. | 14 | 2016-07-28 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-07-06 |
| 8-K | Report of unscheduled material events or corporate changes. | 3 | 2016-06-08 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-06-07 |
| 8-K | Report of unscheduled material events or corporate changes. | 3 | 2016-06-02 |
| Current | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
|---|---|---|---|---|
| Strong Buy | 3 | 2 | 4 | 4 |
| Moderate Buy | 0 | 0 | 0 | 0 |
| Hold | 0 | 1 | 0 | 1 |
| Moderate Sell | 0 | 0 | 0 | 0 |
| Strong Sell | 1 | 1 | 1 | 1 |
| Mean Rec. | 1.83 | 2.33 | 1.66 | 1.88 |
© 2018 Equities
* All dates and time are being displayed in Eastern Standard Time (EST).
